Free Trial

Canada Pension Plan Investment Board Sells 22,900 Shares of Genpact Limited $G

Genpact logo with Computer and Technology background

Key Points

  • Canada Pension Plan Investment Board sold 22,900 shares of Genpact Limited, reducing its stake by 22.2%, and now holds 80,200 shares valued at approximately $4,040,000.
  • Several institutional investors have increased their holdings in Genpact, with 96.03% of the stock currently owned by institutional investors.
  • Genpact recently declared a quarterly dividend of $0.17 per share, with an annualized yield of 1.5%, set to be paid on September 25th.
  • MarketBeat previews the top five stocks to own by October 1st.

Canada Pension Plan Investment Board trimmed its stake in Genpact Limited (NYSE:G - Free Report) by 22.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 80,200 shares of the business services provider's stock after selling 22,900 shares during the period. Canada Pension Plan Investment Board's holdings in Genpact were worth $4,040,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Envestnet Portfolio Solutions Inc. increased its position in shares of Genpact by 59.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 10,355 shares of the business services provider's stock worth $522,000 after purchasing an additional 3,849 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of Genpact by 20.6% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 9,650 shares of the business services provider's stock worth $486,000 after purchasing an additional 1,651 shares during the last quarter. GAMMA Investing LLC boosted its stake in Genpact by 88.0% in the first quarter. GAMMA Investing LLC now owns 9,744 shares of the business services provider's stock worth $491,000 after buying an additional 4,561 shares in the last quarter. 111 Capital purchased a new stake in Genpact in the fourth quarter worth approximately $301,000. Finally, Assenagon Asset Management S.A. purchased a new stake in Genpact in the first quarter worth approximately $2,396,000. 96.03% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Wall Street Zen raised Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. JPMorgan Chase & Co. cut their target price on Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a research note on Wednesday, August 20th. Mizuho upped their target price on Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 1st. Needham & Company LLC upped their target price on Genpact from $50.00 to $53.00 and gave the stock a "buy" rating in a research note on Friday, August 8th. Finally, Deutsche Bank Aktiengesellschaft assumed coverage on Genpact in a research note on Thursday, July 17th. They issued a "hold" rating and a $47.00 target price for the company. Three research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $52.29.

Read Our Latest Stock Report on G

Genpact Stock Performance

NYSE:G opened at $45.12 on Thursday. The firm has a market cap of $7.86 billion, a PE ratio of 14.99, a price-to-earnings-growth ratio of 1.56 and a beta of 0.92. Genpact Limited has a fifty-two week low of $37.82 and a fifty-two week high of $56.76. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.53 and a current ratio of 1.53. The business has a 50 day moving average price of $44.54 and a 200-day moving average price of $46.41.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating analysts' consensus estimates of $0.85 by $0.03. The firm had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.23 billion. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The business's quarterly revenue was up 6.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.79 earnings per share. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Equities research analysts predict that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, September 11th will be paid a $0.17 dividend. The ex-dividend date of this dividend is Thursday, September 11th. This represents a $0.68 dividend on an annualized basis and a yield of 1.5%. Genpact's dividend payout ratio (DPR) is presently 22.59%.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Institutional Ownership by Quarter for Genpact (NYSE:G)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines